Fed’s Powell opens door to potential rate cuts at Jackson Hole
Investing.com - Clearside Biomedical reported on Wednesday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Clearside Biomedical announced earnings per share of $-0.130 on revenue of $260K. Analysts polled by Investing.com EPS of $-0.130 on revenue of $410K.
Clearside Biomedical 's are down 16.73% and is trading at $1.400 , still down 75.67% from its 52 week high of $5.22 set on Wednesday, November 10, 2021.
Clearside Biomedical shares gained 10.24% to trade at $1.400 in pre-market trade the report.
Clearside Biomedical follows other major Healthcare sector earnings this month
Clearside Biomedical's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar